Literature DB >> 6975941

Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytes.

L Liebes, R Krigel, S Kuo, D Nevrla, E Pelle, R Silber.   

Abstract

Human lymphocyte extracts analyzed by high-performance liquid chromatography reveal a major UV-absorbing peak that was shown to be ascorbic acid by spectral, chemical, and enzymatic criteria. Because this peak appeared very prominent in the elution profile of chronic lymphocytic leukemia (CLL) lymphocyte extracts, we measured the ascorbic acid content in lymphocytes from the blood of normal subjects and untreated patients with chronic lymphocytic leukemia. A significantly higher concentration of 111 +/- 15.3 nmol per 10(8) cells (mean +/- SEM) was found in CLL lymphocytes than in normal blood lymphocytes, which contained 42.2 +/- 3.3 nmol per 10(8) cells. Selective enrichment with B and T cells showed that this difference was limited to the chronic lymphocytic leukemia B cell, which had a 5- to 15-fold higher content of ascorbic acid than normal B cells had. In contrast, the ascorbic acid level was similar in normal and CLL T cells. The very high ascorbic acid content provides the chronic lymphocytic leukemia B cell with a reducing substance that could react with oxidants or free radicals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975941      PMCID: PMC349063          DOI: 10.1073/pnas.78.10.6481

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Plasma and leucocyte ascorbic acid concentrations in acute lymphoblastic leukaemia.

Authors:  S C Kakar; C W Wilson; J N Bell
Journal:  Ir J Med Sci       Date:  1975-06       Impact factor: 1.568

2.  The spectrophotometic determination of ascorbic acid in tissue extracts, particularly those of the walnut (Juglans regia).

Authors:  C DAGLISH
Journal:  Biochem J       Date:  1951-10       Impact factor: 3.857

3.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

4.  Oxidation-reduction reactions involving ascorbic acid and the hexosemonophosphate shunt in corneal epithelium.

Authors:  E I Anderson; A Spector
Journal:  Invest Ophthalmol       Date:  1971-01

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Heterogeneity of 5'-nucleotidase activity in lymphocytes in chronic lymphocytic leukemia.

Authors:  J Lopes; D Zucker-Franklin; R Silber
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

7.  Ascorbate and phagocyte function.

Authors:  L Stankova; N B Gerhardt; L Nagel; R H Bigley
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

8.  Changes relevant to catecholamine metabolism in liver and brain of ascorbic acid deficient guinea-pigs.

Authors:  R Deana; B S Bharaj; Z H Verjee; L Galzigna
Journal:  Int J Vitam Nutr Res       Date:  1975       Impact factor: 1.784

9.  Vitamin C supplementation in the elderly: a 17-month trial in an old persons' home.

Authors:  J Andrews; M Letcher; M Brook
Journal:  Br Med J       Date:  1969-05-17

10.  Studies on ascorbic acid. I. Factors influencing the ascorbate-mediated inhibition of catalase.

Authors:  C W Orr
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

View more
  1 in total

1.  High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription.

Authors:  Hiroshi Kawada; Mitsuyo Kaneko; Masakazu Sawanobori; Tomoko Uno; Hideyuki Matsuzawa; Yoshihiko Nakamura; Hiromichi Matsushita; Kiyoshi Ando
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.